基于价值的药物支出:美国的一个理性的计划
1Professor Emeritous, Rutgers Robert Wood Johnson Medical School New Brunswick, Westfield, Mass, United States.
The American journal of medicine
|July 22, 2025
概括
高昂的药物成本是医疗保健的一个主要问题. 拟议的2028年改革包括基于价值的启发式模型和总统委员会进行必要的改变.
科学领域:
- 卫生经济学 卫生经济学
- 医疗保健政策 医疗保健政策
- 医学创新 医学创新
背景情况:
- 目前的医疗保健面临着重大挑战,特别是新型药物的过高成本.
- 解决这些系统性问题需要实质性改革,预计时间表将延长到2028年.
研究的目的:
- 提出改革医疗保健的根本解决方案,重点关注成本控制和价值.
- 引入一种包含价值作为改革的主要标准的启发式模型.
主要方法:
- 开发一个启发式模型来指导改革实施.
- 成立一个由总统任命的特别委员会,负责监督改革.
主要成果:
- 拟议的模型旨在将"价值"作为评估医疗干预和药物定价的中心指标.
- 委员会主席的任命意味着对实施这些变革的高级别承诺.
结论:
- 实施基于价值的启发式模型和专门的总统委员会可以解决药物成本等关键问题.
- 拟议的改革提供了一个结构化的方法,到2028年提高医疗保健的效率和负担能力.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.6K
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
9.8K
相关概念视频
Bioequivalence: Overview
1.2K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.2K
Methods of Documentation V: CBE
983
Charting by Exception, or CBE, is a method of documentation used in healthcare, particularly in nursing, that focuses on documenting only significant or abnormal findings rather than recording every detail. This approach aims to streamline the documentation process, improve efficiency, and ensure that healthcare providers can quickly identify deviations from normalcy in patient assessments.
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
983
Drug Nomenclature
2.3K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
2.3K
Drug Control Governance: Regulatory Bodies and Their Impact
252
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
252
Prescription, Nonprescription and Orphan Drugs
849
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
849
Drug Regulation
1.9K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K
